🌍World BusinessZai Lab Highlights Early Trial Data for ZL-1503 in Atopic Dermatitis Treatment
Zai Lab shared initial Phase 1 findings for its atopic dermatitis drug candidate, ZL-1503, highlighting safety and target engagement in healthy volunteers.